DOCSDoximity, Inc.
$30.49-58% 1Y
$30.49
$18.0152 weeks$75.12
DOCS as reported
Doximity, Inc. reported $656M of revenue over the trailing twelve months, +11% on the year before. 10 reported series are charted on this page, each one as filed.
$656M
Revenue, trailing twelve months · to Q1 2027 · +11% against the twelve months before
- Net income
- $167M
Net income · −29% year on year · trailing twelve months to Q1 2027
- Free cash flow
- $98M
Free cash flow · −67% year on year · trailing twelve months to Q1 2027
- Operating margin
- 29%
Operating margin · trailing twelve months to Q1 2027
Details›
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $656M | +11% | Q1 2027 |
| Net income | $167M | −29% | Q1 2027 |
| EPS | $0.85 | −27% | Q1 2027 |
| Gross margin | 88% | n/a | Q1 2027 |
| Operating margin | 29% | n/a | Q1 2027 |
| Net margin | 25% | n/a | Q1 2027 |
| ROE | 22% | n/a | Q1 2027 |
| ROA | 18% | n/a | Q1 2027 |
| Free cash flow | $98M | −67% | Q1 2027 |
| P/E | 35.9 | n/a | today |
Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.
Doximity, Inc. (DOCS) · Revenue and profitRevenue and profitDoximity, Inc. (DOCS)
RevenueNet incomeTrailing twelve months
Powered byryufin.com
Health Information Services
Ranks #1 of 20 by RyuScore